Department of Experimental Oncology, IEO-European Institute of Oncology IRCCS, 20139 Milan, Italy.
Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Via Cosimo il Vecchio 2, 50139 Florence, Italy.
Int J Environ Res Public Health. 2021 Jul 27;18(15):7945. doi: 10.3390/ijerph18157945.
Over the last decades, the incidence of melanoma has been steadily growing, with 4.2% of the population worldwide affected by cutaneous melanoma (CM) in 2020 and with a higher incidence and mortality in men than in women. We investigated both the risk factors for CM development and the prognostic and predictive factors for survival, stratifying for both sex and gender.
We conducted a systematic review of studies indexed in PUB-MED, EMBASE, and Scopus until 4 February 2021. We included reviews, meta-analyses, and pooled analyses investigating differences between women and men in CM risk factors and in prognostic and predictive factors for CM survival.
Twenty-four studies were included, and relevant data extracted. Of these, 13 studies concerned potential risk factors, six concerned predictive factors, and five addressed prognostic factors of melanoma.
The systematic review revealed no significant differences in genetic predisposition to CM between males and females, while there appear to be several gender disparities regarding CM risk factors, partly attributable to different lifestyles and behavioral habits between men and women. There is currently no clear evidence of whether the mutational landscapes of CM differ by sex/gender. Prognosis is justified by a complex combination of phenotypes and immune functions, while reported differences between genders in predicting the effectiveness of new treatments are inconsistent. Overall, the results emerging from the literature reveal the importance of considering the sex/gender variable in all studies and pave the way for including it towards precision medicine.
Men and women differ genetically, biologically, and by social construct. Our systematic review shows that, although fundamental, the variable sex/gender is not among the ones collected and analyzed.
在过去几十年中,黑色素瘤的发病率一直在稳步上升,2020 年全球有 4.2%的人口患有皮肤黑色素瘤(CM),男性的发病率和死亡率均高于女性。我们研究了 CM 发病的危险因素,以及生存的预后和预测因素,并按性别进行了分层。
我们对 PUB-MED、EMBASE 和 Scopus 中截至 2021 年 2 月 4 日的研究进行了系统综述。我们纳入了评估女性和男性在 CM 危险因素以及 CM 生存的预后和预测因素方面差异的综述、荟萃分析和汇总分析。
共纳入 24 项研究,并提取了相关数据。其中 13 项研究涉及潜在的危险因素,6 项研究涉及预测因素,5 项研究涉及黑色素瘤的预后因素。
系统综述显示,男性和女性在 CM 的遗传易感性方面没有显著差异,而在 CM 危险因素方面存在一些性别差异,部分归因于男性和女性之间不同的生活方式和行为习惯。目前还没有明确的证据表明 CM 的突变景观是否存在性别差异。预后由表型和免疫功能的复杂组合来确定,而报告的性别差异在预测新治疗方法的有效性方面不一致。总的来说,文献中的结果表明,在所有研究中考虑性别变量的重要性,并为纳入精准医学铺平了道路。
男性和女性在遗传、生物学和社会建构方面存在差异。我们的系统综述表明,尽管性别是一个基本变量,但它并不是收集和分析的变量之一。